BACILLUS SPECIES STRAIN EXPRESSING SUPEROXIDE DISMUTASE, BACILLUS SPECIES STRAIN SPORE AND/OR SUPEROXIDE DISMUTASE, AND USE THEREOF FOR PREVENTING OR TREATING OF FIBROTIC DISEASE

The present invention relates to a composition for the prevention, alleviation, or treatment of fibrotic diseases, containing a Bacillus species strain, a Bacillus species strain spore, each expressing superoxide dismutase, and/or superoxide dismutase. When orally administered, the composition allows the polypeptide with superoxide dismutase activity to remove reactive oxygen species in vivo, thus being helpful for the prevention, improvement, or treatment of fibrotic diseases such as pulmonary fibrosis or hepatic fibrosis..

Medienart:

Patent

Erscheinungsjahr:

2024

Erschienen:

2024

Enthalten in:

Europäisches Patentamt - (2024) vom: 07. März Zur Gesamtaufnahme - year:2024

Sprache:

Englisch

Beteiligte Personen:

PAN JAE GU [VerfasserIn]
KIM EUI JOONG [VerfasserIn]
KIM JEONG HYUN [VerfasserIn]
CHANG IN IK [VerfasserIn]
LEE SEI WON [VerfasserIn]

Links:

Volltext [kostenfrei]

Themen:

Sonstige Themen:
615
A23L: Foods, foodstuffs, or non-alcoholic beverages, not (...)
A61K: Preparations for medical, dental, or toilet purpose (...)
A61P: Specific therapeutic activity of chemical compounds (...)
che
tec

Anmerkungen:

Source: www.epo.org (no modifications made), First posted: 2024-03-07, Last update posted on www.tib.eu: 2024-04-10, Last updated: 2024-04-19

Patentnummer:

WO2024049280

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

EPA001558218